EDITORIAL

Should Low-Dose Biophotonic Therapy Have a Role in the Treatment of Type 2 Diabetes (T2DM)

Orien L Tulp.1 Syed AA Rizvi.1,2 

• .1Professor, Colleges of Medicine and Graduate Studies, University of Science, Arts and Technology, Montserrat, British West Indies 
• .2Professor, Larkin Hospital, Miami FL, USA
•  
• Corresponding Author: Orien L. Tulp, Professor, Colleges of Medicine and Graduate Studies, University of Science, Arts and Technology, Montserrat, British West Indies. E-mail: [email protected]
•  

Received: January 13, 2025                                                     Published: January 21, 2025

Citation: Tulp O. Should Low-Dose Biophotonic Therapy Have a Role in the Treatment of Type 2 Diabetes (T2DM). Int J Complement Intern Med. 2025;7(1):300–304. DOI: 10. 58349/IJCIM. 1. 7. 2025. 00145

Copyright: ©2025 Tulp O. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Keywords: Biophotonics, Diabetes, Hemoglobin A1c, SpO2

References 

1. Frysh P. Sunlight and your health. Web MD 2022. 

2. Krasnovsky A Jr, Drozdova NN, Ya V, et al. Sun source of photons – biophotonics of molecular oxygen: activation efficiencies and upon direct upon direct photosensitized excitation. Clin Opt Lett. 2005;3:81-84. 

3. Tulp OL, Einstein GP. Can biophotonic therapy ameloriate the metabolic sequelae of NIDDM? Int J Comp Alt Med. 2024:17, 97-101. Hockberger, P.E. A history of UV photobiology for humans, animals and microorganisms. Photochem Photobiol. 2002:76:561- 579. 

4. Miley G. Ultraviolet blood therapy in acute pyogenic infections. In: Proceedings of local branches of the American Societies for bacteriologists, Eastern Pennsylvania Section, 1943. J Bacteriol.1943;45(3):UV303. 

5. Webb AR, DeCosta BR, Holick MF. Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab. 1989;68(5);882-887. 

6. Tulp OL, Rizvi SAA, Einstein GP. Effects of biophotonic treatment on hemoglobin A1c and blood oxygen saturation. ES J clon Trials. 2024;12(1). 

7. Sameja M, Melotti D, Carenini A, et al. Glycosylated hemoglobin and the oxygen affinity of whole blood. Diabetologia. 1982;23(5): 399-402. 

8. Gong L, Zou Z, Liu L, et al. Photomodulation therapy ameliorates hyperglycemia and insulin resistance by activating cytochrome c oxidase-mediated protein kinase B in muscle. Aging. 2021;13(7):10015-10033. 

9. Tulp OL, Rizvi SAA, Einstein GP. Effects of biophotonic treatment on hemoglobologic parameters. Preprints.org, 2024. 

10. Koenig RJ, Cerami A. Hemoglobon A1c and diabetes mellitus. Ann Rev of Medicine. 1980;3;29- 34. 

11. Kahn CR. Role of insulin receptors in insulin resistant states. Metabolism. 1980:29(5);455-466. 

12. Tulp OL, Einstein G P. Efficacy of Biophotonic adjunct in viral and microbial infections. J Contemporary Med Educ. 2023;32(12):1-14. 

13. Patwardian RS, Checker R. Involvement of ERK-Nf2 signalling in ionizing radiation induced cell death in normal and tumor cells. PloS ONE. 2013;8(6):e65929. 

14. Karakaya J, Akin S, Karagaoglu E, et al. The performance of hemoglobin A1c against fasting plasma glucose and oral glucose tolerance test in detecting prediabetes and diabetes. J Res Med Sci. 2014;19(11):1051-1057. 

15. Syed M Imam, Orien L Tulp, Syed AA Rizvi, et al. Incretin mimetics for the management of diabetes and associated comorbidities: An overview. Innovative Medicines & Omics. 2024;4911.